Skip to Main Content

Imaging pancreatic beta-cells with PET neuroimaging agent 11C-PHNO

Conditions

Diseases of the Nervous System

Phase I

What is the purpose of this trial?

We are conducting a PET imaging study to develop a way to measure the number of insulin secreting cells in the pancreas. This study is intended for people diagnosed with Type 2 Diabetes who are otherwise in good physical health and well controlled on insulin. The study requires 2-3 visits over several weeks.

  • Trial with
    Yale University School of Medicine
  • Start Date
    09/05/2017
  • End Date
    07/31/2021

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000021287